Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.004 Å; R factor = 0.034; wR factor = 0.099; data-to-parameter ratio = 7.1.
The molecule of the title compound, C 35 H 27 N 3 O 2 , lies on a twofold rotation axis passing through the pyridine ring. The five-membered ring is approximately flat (r.m.s. deviation = 0.065 Å ) and is essentially coplanar [dihedral angle = 4.2 (2) ] with the pyridine ring.
Related literature
For the synthesis of the precursor, see: Desimoni et al. (2001) . For the structure of 2,6-bis(2-oxazolinyl)pyridine, see: Sada et al. (2003) . 
Experimental

Comment
We report here the cyclization of the two side arms of (2,6-bis [(1R,2S) N,N'-2-chloro-1,2-diphenylethyl]-pyridinedicarboxamide to form a di-substituted pyridine having two 1,3-oxazoline rings. The title compound is intended for an evaluation of its phamaceutical properties. It lies on a twofold rotation axis that passes through the pyridine ring (Fig. 1) . The five-membered ring is approximately flat [r.m.s. deviation 0.065 Å] and is nearly coplanar [dihedral angle 4.2 (2)°] with the pyridine ring.
In the parent compound, 2,6-bis(2-oxazolinyl)pyridine, the three rings are similarly nearly coplanar (Sada et al., 2003) .
Experimental
To a suspension of 2,6-bis [(1R,2S) (26 ml), an equeous solution of 2 N sodium hydroxide (13 ml) was added and the mixture was refluxed 8 h. The hot suspension was filtered and the white solid was washed with water (0.73 g, yield 90%). Crystals were obtained by recrystallization from ethyl acetate; m.p. 474-474 K.
Refinement
H atoms were placed in calculated positions (C-H 0.93-0.99 Å) and were included in the refinement in the riding model approximation, with U(H) set to 1.2U eq (C); 768 Friedel pairs were merged. The absolute configuration was assumed to be that of the reactant. 
